{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:52:16Z","timestamp":1792806736736,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CPJ1-0044-01"],"award-info":[{"award-number":["ANR-22-CPJ1-0044-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"P.M. was partially supported by E.S.T. Engineering Ship Technology Pte Ltd."},{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS 2024.03"],"award-info":[{"award-number":["DKS 2024.03"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["ADDRess program (01GM2205A)"],"award-info":[{"award-number":["ADDRess program (01GM2205A)"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007380","name":"Fondation de l'Avenir pour la Recherche M\u00e9dicale Appliqu\u00e9e","doi-asserted-by":"publisher","award":["ERiCAN program"],"award-info":[{"award-number":["ERiCAN program"]}],"id":[{"id":"10.13039\/100007380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Abnormal RNA splicing is an underrecognized driver of pathogenicity in germline\n                    <jats:italic>TP53 \u2014<\/jats:italic>\n                    the cause of Li\u2013Fraumeni syndrome (LFS). We re-evaluated exonic single-nucleotide variants (SNVs) that yield missense or synonymous changes for spliceogenic effects by integrating SpliceAI prediction, in-vitro minigene assays, and analysis of tumor RNA-seq from TCGA, and assessed genotype-phenotype correlations using clinical data from multiple databases and national registries. We identified 58 spliceogenic exonic SNVs (SE-SNVs) across the\n                    <jats:italic>TP53<\/jats:italic>\n                    gene (40 missense, 18 synonymous). Experimental validation confirmed aberrant splicing for 15 out of 17 tested variants, most often through cryptic splice-site activation that introduced frameshifts and premature termination. Clinically, carriers of SE-SNVs previously considered as mild or of low-pathogenicity by protein-based assays showed earlier onset and LFS-signature cancers, indicating that splicing disruption can override amino-acid effects. The recurrent c.375\u2009G\u2009&gt;\u2009A (p.(Thr125\u2009=\u2009)) showed heterogeneous effect: with both childhood\/adolescent and adult onset, consistent with partial, variable retention of canonical splicing. These data reveal a substantial burden of spliceogenic pathogenicity in\n                    <jats:italic>TP53<\/jats:italic>\n                    and strong support integrating splicing prediction, functional validation, and transcript-level evidence into variant interpretation and risk stratification in LFS.\n                  <\/jats:p>","DOI":"10.1038\/s41431-026-02061-6","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:57:13Z","timestamp":1772575033000},"page":"1112-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing"],"prefix":"10.1038","volume":"34","author":[{"given":"Deborah","family":"Sch\u00f6negger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Montellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Freycon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1978-4998","authenticated-orcid":false,"given":"Paola","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-3121","authenticated-orcid":false,"given":"Catherine","family":"Goudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1475-0254","authenticated-orcid":false,"given":"Ga\u00eblle","family":"Bougeard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-5873","authenticated-orcid":false,"given":"Christian P.","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-7918","authenticated-orcid":false,"given":"Anna","family":"Reymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1947601911413466","volume":"2","author":"D Malkin","year":"2011","unstructured":"Malkin D. Li-Fraumeni syndrome. Genes Cancer. 2011;2:475\u201384.","journal-title":"Genes Cancer"},{"key":"2061_CR2","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, et al. Revisiting Li-Fraumeni syndrome From TP53 mutation carriers. J Clin Oncol. 2015;33:2345\u201352.","journal-title":"J Clin Oncol"},{"key":"2061_CR3","doi-asserted-by":"publisher","first-page":"a026179","DOI":"10.1101\/cshperspect.a026179","volume":"6","author":"P Hainaut","year":"2016","unstructured":"Hainaut P, Pfeifer GP. Somatic TP53 mutations in the era of genome sequencing. Cold Spring Harb Perspect Med. 2016;6:a026179.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2061_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/carcin\/bgaa117","volume":"41","author":"Y Stein","year":"2020","unstructured":"Stein Y, Aloni-Grinstein R, Rotter V. Mutant p53 oncogenicity: dominant-negative or gain-of-function? Carcinogenesis. 2020;41:1635\u201347.","journal-title":"Carcinogenesis"},{"key":"2061_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111296","volume":"27","author":"E Montellier","year":"2024","unstructured":"Montellier E, Lemonnier N, Penkert J, Freycon C, Blanchet S, Amadou A, et al. Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome. iScience. 2024;27:111296.","journal-title":"iScience"},{"key":"2061_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23:135\u201355.","journal-title":"Nat Rev Cancer"},{"key":"2061_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qian J, Gu C, Yang Y. Alternative splicing and cancer: a systematic review. Signal Transduct Target Ther. 2021;6:78.","journal-title":"Signal Transduct Target Ther"},{"key":"2061_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74892-2","volume":"10","author":"V Carbonnier","year":"2020","unstructured":"Carbonnier V, Leroy B, Rosenberg S, Soussi T. Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries. Sci Rep. 2020;10:20368.","journal-title":"Sci Rep"},{"key":"2061_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","volume":"57","author":"JS Funk","year":"2025","unstructured":"Funk JS, Klimovich M, Drangenstein D, Pielhoop O, Hunold P, Borowek A, et al. Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations. Nat Genet. 2025;57:140\u201353.","journal-title":"Nat Genet"},{"key":"2061_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"30","author":"A Amadou","year":"2018","unstructured":"Amadou A, Waddington Achatz MI, Hainaut P. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li\u2013Fraumeni syndrome. Curr Opin Oncol. 2018;30:23\u201329.","journal-title":"Curr Opin Oncol"},{"key":"2061_CR11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","volume":"28","author":"T Frebourg","year":"2020","unstructured":"Frebourg T, Bajalica Lagercrantz S, Oliveira C, Magenheim R, Evans DG. Guidelines for the Li\u2013Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet. 2020;28:1379\u201386.","journal-title":"Eur J Hum Genet"},{"key":"2061_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/humu.24152","volume":"42","author":"C Fortuno","year":"2021","unstructured":"Fortuno C, Lee K, Olivier M, Pesaran T, Mai PL, Andrade KC, et al. Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants. Hum Mutat. 2021;42:223\u201336.","journal-title":"Hum Mutat"},{"key":"2061_CR13","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","volume":"7","author":"CP Kratz","year":"2021","unstructured":"Kratz CP, Freycon C, Maxwell KN, Nichols KE, Schiffman JD, Evans DG, et al. Analysis of the Li-Fraumeni spectrum based on an international germline TP53 variant data set. JAMA Oncol. 2021;7:1800.","journal-title":"JAMA Oncol"},{"key":"2061_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63528-6","volume":"16","author":"NW Fischer","year":"2025","unstructured":"Fischer NW, Ong N, Laverty B, Psarianos P, Giovino C, Alon N, et al. TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup. Nat Commun. 2025;16:8546.","journal-title":"Nat Commun"},{"key":"2061_CR15","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","volume":"100","author":"S Kato","year":"2003","unstructured":"Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA. 2003;100:8424\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2061_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-024-00714-5","volume":"19","author":"C Fortuno","year":"2025","unstructured":"Fortuno C, Llinares-Burguet I, Canson DM, de la Hoya M, Bueno-Mart\u00ednez E, Sanoguera-Miralles L, et al. Exploring the role of splicing in TP53 variant pathogenicity through predictions and minigene assays. Hum Genomics. 2025;19:2.","journal-title":"Hum Genomics"},{"key":"2061_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41418-022-00976-3","volume":"29","author":"KC de Andrade","year":"2022","unstructured":"de Andrade KC, Lee EE, Tookmanian EM, Kesserwan CA, Manfredi JJ, Hatton JN, et al. The TP53 database: transition from the International Agency for Research on Cancer to the US National Cancer Institute. Cell Death Differ. 2022;29:1071\u20133.","journal-title":"Cell Death Differ"},{"key":"2061_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-022-01332-1","volume":"15","author":"J Penkert","year":"2022","unstructured":"Penkert J, Str\u00fcwe FJ, Dutzmann CM, Doergeloh BB, Montellier E, Freycon C, et al. Genotype\u2013phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry. J Hematol Oncol. 2022;15:107.","journal-title":"J Hematol Oncol"},{"key":"2061_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535\u2013.e24.","journal-title":"Cell"},{"key":"2061_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.tig.2018.04.005","volume":"34","author":"M Tomkova","year":"2018","unstructured":"Tomkova M, Schuster-B\u00f6ckler B. DNA modifications: naturally more error prone? Trends Genet. 2018;34:627\u201338.","journal-title":"Trends Genet"},{"key":"2061_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-023-00451-1","volume":"17","author":"JM de Sainte Agathe","year":"2023","unstructured":"de Sainte Agathe JM, Filser M, Isidor B, Besnard T, Gueguen P, Perrin A, et al. SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation. Hum Genomics. 2023;17:7.","journal-title":"Hum Genomics"},{"key":"2061_CR22","doi-asserted-by":"publisher","unstructured":"Velkova I, Cappato S, Rivera D, Romano F, Schoenegger D, Bocciardi R, et al. Missense but mis-spliced: germline TP53 variant c.671A>C (p.E224A) and the path from uncertainty to pathogenicity. medRxiv; 2025, https:\/\/doi.org\/10.1101\/2025.07.31.25332437.","DOI":"10.1101\/2025.07.31.25332437"},{"key":"2061_CR23","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3390\/cancers13133341","volume":"13","author":"A Moles-Fern\u00e1ndez","year":"2021","unstructured":"Moles-Fern\u00e1ndez A, Dom\u00e8nech-Viv\u00f3 J, Ten\u00e9s A, Balma\u00f1a J, Diez O, Guti\u00e9rrez-Enr\u00edquez S. Role of splicing regulatory elements and in silico tools usage in the identification of deep intronic splicing variants in hereditary breast\/ovarian cancer genes. Cancers (Basel). 2021;13:3341.","journal-title":"Cancers (Basel)"},{"key":"2061_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/humu.24212","volume":"42","author":"TV Riepe","year":"2021","unstructured":"Riepe TV, Khan M, Roosing S, Cremers FPM, \u2019t Hoen PAC. Benchmarking deep learning splice prediction tools using functional splice assays. Hum Mutat. 2021;42:799\u2013810.","journal-title":"Hum Mutat"},{"key":"2061_CR25","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya Mdela, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023;110:1046\u201367.","journal-title":"Am J Hum Genet"},{"key":"2061_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-024-00586-9","volume":"18","author":"H Wu","year":"2024","unstructured":"Wu H, Lin JH, Tang XY, Marenne G, Zou WB, Schutz S, et al. Combining full-length gene assay and SpliceAI to interpret the splicing impact of all possible SPINK1 coding variants. Hum Genomics. 2024;18:21.","journal-title":"Hum Genomics"},{"key":"2061_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0378-1119(95)00223-S","volume":"161","author":"TC Burn","year":"1995","unstructured":"Burn TC, Connors TD, Klinger KW, Landes GM. Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene. 1995;161:183\u20137.","journal-title":"Gene"},{"key":"2061_CR28","doi-asserted-by":"publisher","unstructured":"Tompson S, Young T. Assaying the effects of splice site variants by exon trapping in a mammalian cell line. Bio-protocol. 2017;7, https:\/\/doi.org\/10.21769\/BioProtoc.2281","DOI":"10.21769\/BioProtoc.2281"},{"key":"2061_CR29","doi-asserted-by":"publisher","first-page":"e1006360","DOI":"10.1371\/journal.pcbi.1006360","volume":"14","author":"D Garrido-Mart\u00edn","year":"2018","unstructured":"Garrido-Mart\u00edn D, Palumbo E, Guig\u00f3 R, Breschi A. ggsashimi: Sashimi plot revised for browser- and annotation-independent splicing visualization. Pertea M, editor. PLOS Comput Biol. 2018;14:e1006360.","journal-title":"PLOS Comput Biol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02061-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:02:11Z","timestamp":1785445331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02061-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02061-6","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Public datasets (IARC\/NCI TP53 Database R21, COSMIC v94, and gnomAD v4.1.0) are openly available and did not require ethical approval. Access to controlled TCGA RNA-Seq data was granted under dbGaP authorization (NCI dbGaP Study Accession: phs000178.v11.p8), and the use of de-identified data complied with TCGA and dbGaP access policies. Validation cohort data were used with ethical approval from the Ethics Committee of Hannover Medical School (Germany) and the French National Ethics Committee.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}